The Discounted Cash Flow (DCF) valuation of Acacia Pharma Group PLC (ACPH.BR) is (293,426.57) EUR. With the latest stock price at 0.89 EUR, the upside of Acacia Pharma Group PLC based on DCF is -33043632.4%.
Based on the latest price of 0.89 EUR and our DCF valuation, Acacia Pharma Group PLC (ACPH.BR) is a sell. selling ACPH.BR stocks now will result in a potential gain of 33043632.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.8% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (691,507.87) - (184,815.61) | (293,426.57) |
| Upside | -77872607.6% - -20812669.0% | -33043632.4% |